Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant

SAN JOSE, Calif. and STUTTGART, Germany, Dec. 7, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. , a biotechnology company focused on the treatment and prevention of cancer and infectious... | December 7, 2021

Related Keywords

Germany ,Eric Ribner ,Anixa Biosciences ,Amit Kumar ,Lutz Weber ,Mike Catelani ,Molgenie Gmb ,Anixa Biosciences Inc ,Lifesci Advisors ,Lifesci Communications ,Company Contact ,Nasdaq ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Operating Officer ,Chief Financial ,Salve Nissan ,Sci Advisors ,Nc Stock Exchange ,News ,Information ,Press Release ,Han ,End ,021 ,Biotechnology ,Company ,Ocused ,N ,The ,Treatment ,Prevention ,F ,Dancer ,Nd Anix Us03528h1095 ,